Search Results
Erythropoiesis Stimulating Agents and other Growth Factors in Low-risk MDS: An update
ESA and other growth factors for MDS
What are erythropoietin-stimulating agents (ESAs)?
Options in Low-Risk Disease MDS
COMMANDS trial: luspatercept vs epoetin alfa in lower-risk MDS
ESAs for the management of lower-risk MDS
Transfusion-dependant, low-risk MDS: what are the options?
Trial updates for luspatercept in LR-MDS: COMMANDS, MEDALIST and ELEMENTS-MDS
The impact of ESAs in lower-risk MDS
Luspatercept Correlated with Clinical Benefit in Patients with Lower-risk MDS
Options for Treatment of MDS
MDS: Low-Risk Disease Treatment Options
